JENIFFER ALBERRY: Open Payments
NPI 1407898356 · ALEXANDRIA BAY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 14 payments from 9 companies in 2025. Trend: 2023 $386 · 2024 $472 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $110 |
| ABBVIE INC. | 3 | $56 |
| Madrigal Pharmaceuticals | 1 | $44 |
| Lilly USA, LLC | 2 | $35 |
| Amgen Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: AREXVY, VRAYLAR, REZDIFFRA, MOUNJARO, OTEZLA, XIFAXAN, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
